Fresenius buys heparin maker APP
The Associated Press reported today that German dialysis clinic operator Fresenius has been approved to purchase APP Pharmaceuticals. APP makes injectable drugs, including heparin, and just announced its plans to begin manufacturing heparin at its Puerto Rico facility after receiving approval by the U.S. Food & Drug Administration (FDA).